Capital Flow Monitor · Sponsors · CIK 1805698
EIKONOKLASTES THERAPEUTICS, INC.
2356 PARK AVENUE, CINCINNATI, OH, 45206 · (513) 549-6484
Pharmaceuticals · Corporation· inc. DELAWARE true
Fit score
—
Offering
$18.6M
Sold
$16.1M
% sold
86.1%
Investors
15
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | D/A ·current | 506(b) | $18.6M | $16.1M | 86.1% | 15 | EDGAR ↗ |
| 2025-07-29 | D | 506(b) | $15.8M | $13.6M | 86.0% | 14 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Bruce Halpryn — Executive Officer / Director, Cincinnati, OH
-
Samuel Lee — Executive Officer / Director, Cincinnati, OH
4 other raises
- Black Lotus Onshore Fund LP $3.0M of —
- Black Lotus Offshore Fund Ltd. $0 of —
- SVRN Multi-Strategy Fund, LP $7.1M of —
- SVRN Crypto Fund, LP $3.0M of —
- Kenneth Morand — Director, Cincinnati, OH
- Thomas Finn — Director, Cincinnati, OH
-
Robert Johnson — Director, Cincinnati, OH
2 other raises
- Michigan State University Federal Credit Union $75.0M of $75.0M · 100.0%
- Youme Healthcare, Inc. $2.9M of $3.5M · 82.0%
-
Joseph Nolan — Director, Cincinnati, OH
1 other raise
- Akava Therapeutics Inc. $0 of $15.0M · 0.0%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.